Close Menu

NEW YORK – Waters reported on Tuesday that its revenues in the third quarter were up 3 percent.

Waters posted revenues of $593.8 million in Q3 compared to $577.3 million in Q3 2019 and beating the average Wall Street estimate of $546.5 million. Waters said that foreign currency translation boosted sales growth by around 1 percent in the quarter.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A Harvard-led team reprogrammed DNA methylation patterns of mice with eye problems to restore their sight, AFP reports.

A man in India is suing the Serum Institute of India, saying that he suffered serious side effects from a vaccine it is testing, but the institute has rejected those claims, the Economic Times reports.

The New York Times reports Moderna is planning a clinical trial of its SARS-CoV-2 vaccine in children.

In Nature this week: Readfish tool for targeted nanopore sequencing, genomic diversity of barley and wheat, and more.